Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chronic bronchitis, COPD].

H R Wirtz1

  • 1Abteilung Pneumologie, Medizinische Klinik I, Universitätsklinikum Leipzig. wirtzh@medizin.uni-leipzig.de

Der Internist
|January 19, 2005
PubMed
Summary
This summary is machine-generated.

Chronic bronchitis, a precursor to COPD, involves airway inflammation and lung damage, primarily from smoking. Management focuses on bronchodilation, exacerbation control, and supportive therapies like smoking cessation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Effect of ambroxol on surfactant secretion and synthesis in isolated type II alveolar cells].

Pneumologie (Stuttgart, Germany)·2000
Same author

The effects of mechanical forces on lung functions.

Respiration physiology·2000
Same author

Acute influence of cigarette smoke on secretion of pulmonary surfactant in rat alveolar type II cells in culture.

The European respiratory journal·1996
Same author

Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells.

Science (New York, N.Y.)·1990
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
Same journal

Der Internist·2024
See all related articles

Area of Science:

  • Pulmonary Medicine
  • Pathology

Context:

  • Chronic bronchitis is a key component and precursor to Chronic Obstructive Pulmonary Disease (COPD).
  • COPD development is influenced by genetic susceptibility and environmental factors, predominantly cigarette smoke exposure.
  • The disease involves inflammation in bronchial and bronchiolar walls, leading to structural damage in airways and lung parenchyma.

Purpose:

  • To outline the pathological basis and clinical variability of chronic bronchitis and COPD.
  • To describe current therapeutic strategies, including pharmacologic and non-pharmacologic interventions.
  • To emphasize the role of acute exacerbations in disease progression.

Summary:

  • Chronic bronchitis is characterized by inflammation and structural damage to airways and lung parenchyma, often coexisting with emphysema and fibrosing bronchiolitis.

Related Experiment Videos

  • Disease presentation is variable, influenced by genetic and environmental risk factors.
  • Treatment involves inhaled bronchodilators, management of acute exacerbations (potentially requiring ventilation), and non-pharmacologic measures.

    • Impact:

    • Highlights the multifactorial nature of COPD, linking chronic bronchitis to broader disease pathology.
    • Underscores the importance of comprehensive management strategies, including pharmacological and non-pharmacological approaches.
    • Informs clinical practice regarding treatment adaptation and consideration of advanced therapies for COPD patients.